PHAT R&D Expenses
Phathom Pharmaceuticals Inc · R&D Expenses
PHAT R&D Expenses
Latest reported$7.81Mperiod ending
PHAT Quarterly R&D Expenses ($0.00 → $7.81M)
Quarterly R&D Expenses
High-resolution chart · PNG
PHAT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 7,813,000 | |
| 7,771,000 | |
| 7,493,000 | |
| 7,027,000 | |
| 9,076,000 | |
| 9,184,000 | |
| 8,583,000 | |
| 8,693,000 | |
| 7,376,000 | |
| 9,430,000 | |
| 13,393,000 | |
| 12,263,000 | |
| 12,764,000 | |
| 11,479,000 | |
| 15,946,000 | |
| 19,020,000 | |
| 18,815,000 | |
| 17,660,000 | |
| 13,553,000 | |
| 16,608,000 | |
| 21,597,000 | |
| 20,580,000 | |
| 41,654,000 | |
| 25,770,000 | |
| 14,859,000 | |
| 15,865,000 | |
| 12,704,000 | |
| 4,469,000 | |
| 81,669,000 | |
| 429,000 | |
| 14,000 | |
| 6,000 | |
| 0 | |
| 0 |